• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The chronic myeloproliferative disorders: an historical perspective.

作者信息

Steensma David P

机构信息

Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

Curr Hematol Rep. 2003 May;2(3):221-30.

PMID:12901343
Abstract

To comprehend the present and chart an informed course for the future, it is essential to be aware of the past. Fifty years ago, William Dameshek introduced the conceptual construct of myeloproliferative disorders, a watershed event in the evolution of thought regarding that peculiar cluster of similar marrow conditions. The four major disorders that comprise the myeloproliferative group, polycythemia vera, chronic myeloid leukemia, myelofibrosis with myeloid metaplasia, and essential thrombocythemia, have interesting and instructive histories. This narrative review explores some of the most noteworthy episodes in those stories, from first descriptions to current understanding.

摘要

相似文献

1
The chronic myeloproliferative disorders: an historical perspective.
Curr Hematol Rep. 2003 May;2(3):221-30.
2
Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.慢性骨髓增殖性疾病的发病机制:真性红细胞增多症、原发性血小板增多症、特发性骨髓化生及慢性粒细胞白血病。
Semin Hematol. 1999 Jan;36(1 Suppl 2):3-8.
3
The history of myeloproliferative disorders: before and after Dameshek.
Leukemia. 2008 Jan;22(1):3-13. doi: 10.1038/sj.leu.2404946. Epub 2007 Sep 20.
4
[Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].[骨髓活检在慢性骨髓增殖性疾病中的预后价值]
Recenti Prog Med. 2003 Jul-Aug;94(7-8):314-20.
5
The role of beta-catenin in chronic myeloproliferative disorders.β-连环蛋白在慢性骨髓增殖性疾病中的作用。
Hum Pathol. 2008 Oct;39(10):1454-8. doi: 10.1016/j.humpath.2008.02.007. Epub 2008 Jul 11.
6
Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.骨髓活检(BMB)。二、骨髓增殖性疾病中的骨髓活检。
Morphol Embryol (Bucur). 1989 Apr-Jun;35(2):117-27.
7
Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.费城染色体阴性慢性骨髓增殖性疾病的分子特征研究进展
Curr Opin Oncol. 2007 Nov;19(6):628-34. doi: 10.1097/CCO.0b013e3282f0e20c.
8
The management of elderly patients with myeloproliferative disorders.老年骨髓增殖性疾病患者的管理
Hematol Oncol. 1993;11 Suppl 1:39-41.
9
[Use of interferon in the treatment of chronic myeloproliferative disorders].[干扰素在慢性骨髓增殖性疾病治疗中的应用]
Acta Haematol Pol. 1992;23(2 Suppl 1):30-7.
10
[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].慢性骨髓增殖性疾病诊断的新方法——JAK2 突变检测
Orv Hetil. 2006 Nov 12;147(45):2175-9.

引用本文的文献

1
Two different point mutations in ABL gene ATP-binding domain conferring Primary Imatinib resistance in a Chronic Myeloid Leukemia (CML) patient: A case report.慢性粒细胞白血病(CML)患者中ABL基因ATP结合域的两种不同点突变导致原发性伊马替尼耐药:一例报告。
Biol Proced Online. 2004;6:144-148. doi: 10.1251/bpo83. Epub 2004 Jul 1.